What is the latest market price of a box of entrectinib 2025?
Entrectinib is a targeted therapy drug mainly used to treat locally advanced or metastatic non-small cell lung cancer (NSCLC) carrying NTRK gene fusion or ROS1 rearrangement and other related solid tumors. The drug effectively controls tumor progression by inhibiting specific tumor growth signaling pathways. In recent years, with the development of genetic testing technology, more and more patients can obtain personalized treatment plans through precision medicine. Entrectinib, as an important targeted drug, has gradually become one of the treatment options for these patients. Clinical studies of entrectinib have shown that many patients experienced significant tumor shrinkage after using the drug, improving their quality of life and survival.

In China, the original drug of entrectinib is marketed in capsule form and has been included in medical insurance, which provides financial support to patients who meet the indications and allows them to reduce their financial burden when receiving treatment. Common specifications on the market include100mg in 30-capsule packaging and 200mg in 90-capsule packaging. The price is approximately more than 20,000 yuan per box. These prices, while higher, are still considered reasonable given the cost of developing the drug and its clinical importance. In addition, the price of entrectinib is generally high in overseas markets. For example, 200mg*90 tablets may cost more than 40,000 yuan. This price varies due to exchange rate fluctuations.
In addition to the original drug, some generic drugs of entrectinib have also appeared on the market. Although these generic drugs contain roughly the same ingredients as the brand-name drugs, the price is usually lower. For example, the price of a 100mg 60-capsule generic drug from a Lao pharmaceutical factory is between more than 1,000 yuan, which provides more treatment options for some patients with limited financial conditions, although the quality and efficacy of generic drugs still need to be fully understood before use.
Reference materials:https://www.roche.com/products/rozlytrek
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)